COVID-19 Data Analysis Using Bayesian Models and Nonparametric Geostatistical Models

Since December 2019, many statistical spatial–temporal methods have been developed to track and predict the spread of the COVID-19 pandemic. In this paper, we analyzed the COVID-19 dataset which includes the number of biweekly infected cases registered in Ontario from March 2020 to the end of June 2021. We made use of Bayesian Spatial–temporal models and Area-to-point (ATP) and Area-to-area (ATA) Poisson Kriging models. With the Bayesian models, spatial–temporal effects and government intervention effects on infection risk are considered while the ATP Poisson Kriging models are used to display the spread of the pandemic over space. © 2023 by the authors.

Latest progress of study on etiology of myopia

In recent years, with the development of social economy, the progress of science and technology and the change of life style, the prevalence of myopia has increased year by year and has a younger trend, and with the outbreak of COVID-19, children and adolescents attending short-distance online classes for a long time has accelerated the occurrence and development of myopia. Visual impairment caused by myopia and serious complications caused by high myopia have seriously affected people's quality of life, study and work. Therefore, the World Health Organization, the International Association for the Prevention of Blindness and China's health departments have put the prevention and control of myopia among children and adolescents on the agenda. However, the etiology is complex, and now it is considered to be related to genetic, environmental and other factors, which is briefly discussed in this review.

Treatment of RAAS inhibitors for hypertensive patients in the coronavirus disease 2019 pandemic from ESH/ISH/AHA statements

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.

Mechanism of Tanreqing Capsule on treatment of coronavirus disease 2019 based on network pharmacology

Objective: To explore the network regulation mechanism of Tanreqing Capsule (TRQC) on the treatment of coronavirus disease 2019 (COVID-19). Methods: Potential targets of the 19 major constituents in TRQC were predicted by the Swiss Target Prediction server and TCMSP database. Gene ontology (GO) function enrichment and pathway analysis of the targets were analyzed by Omicsbean analytic system and String 10 database. Finally, Cytoscape 3.6.1 software was used to construct the network pharmacology map. Results: A total of 19 compounds affected 68 pathways such as IL-17 signaling pathway, T cell receptor signaling pathway, arachidonic acid metabolism, cAMP signaling pathway, PI3K-Akt signaling pathway, influenza A, etc, by acting on 163 related targets, which associated with anti-inflammation, immune regulation, antipyresis, eliminating phlegm, relieving cough and asthma, analgesia, antibacterial and antiviral, and sedation. The network of "compound-target-pathway-pharmacological action-efficacy" was also constructed. Conclusion: The major constituents in TRQC, including scutellarin, baicalin, oroxylin-7-O-glucuronide, chrysin-7-O-glucuronide, forsythin, forsythiaside E, forsythiaside D, chlorogenic acid, caffeic acid, isochlorogenic acid A, ursodeoxycholic acid and chenodeoxycholic acid, may interfere with efficacy-related biological processes associated with antipyresis, eliminating phlegm and removing toxin by acting on key protein like TNF, EGFR, NOS3, PTGS2, IL2, GABBR1, MAPK14, ADRB2, REN, VCAM1, ACHE, PTPRC, etc.

[Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].

Respiratory support is a very important technique for saving severe 2019-nCoV pneumonia patients who suffering respiratory failure, which can improve oxygenation, reduce mortality. Therefore, how to reasonable using respiratory support technique is the key point that relating success or failure. In this paper, the authors introduce their experience on treating severe 2019-nCoV pneumonia, it is hopeful for current fighting against 2019-nCoV in China.